Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 70 out of 100. Prevention and risk

Topic: Risk, prevention and care in population studies

Plain-language summary

Importance Hearing loss has been suggested as a risk factor for dementia, but there is still a need for high-quality research to better understand the association between these 2 conditions and the underlying causal mechanisms and treatment benefits using larger cohorts and detailed data. Objective To investigate the association between hearing loss and incident dementia, as well as how hearing aid use contributes to this association. Design, setting, and participants This population-based cohort study was conducted in Southern Denmark between January 2003 and December 2017 and included all residents 50 years and older. We excluded all persons with dementia before baseline as well as those who did not live in the region 5 years before baseline, with incomplete address history, or who had missing covariate information. Exposures Individual hearing status based on the Hearing Examinations in Southern Denmark database, which contains data on all pure-tone audiometry examinations performed at public hearing rehabilitation clinics in Southern Denmark. Main outcomes and measures Incident cases of dementia and Alzheimer disease as identified from national registries. Results The study population comprised 573 088 persons (298 006 women [52%]; mean [SD] age, 60.8 [11.3] years) with 23 023 cases of dementia and mean (SD) follow-up of 8.6 (4.3) years. Having a hearing loss was associated with an increased risk of dementia, with an adjusted hazard ratio (HR) of 1.07 (95% CI, 1.04-1.11) compared with having no hearing loss. Severe hearing loss in the better and worse ear was associated with a higher dementia risk, with an HR of 1.20 (95% CI, 1.09-1.32) and 1.13 (95% CI, 1.06-1.20), respectively, compared with having no hearing loss in the corresponding ear. Compared with people without hearing loss, the risk of dementia was higher among people with hearing loss who were not using hearing aids than those who had hearing loss and were using hearing aids, with HRs of 1.20 (95% CI, 1.13-1.27) and 1.06 (95% CI, 1.01-1.10), respectively. Conclusions and relevance The results of this cohort study suggest that hearing loss was associated with increased dementia risk, especially among people not using hearing aids, suggesting that hearing aids might prevent or delay the onset and progression of dementia. The risk estimates were lower than in previous studies, highlighting the need for more high-quality longitudinal studies.

What this study adds

Evidence grade: Moderate

This is a follow-up (cohort) study of 573,088 participants. This population-based cohort study of 573,088 people in Southern Denmark found that hearing loss was associated with an increased risk of dementia, with severe hearing loss linked to higher risk. Reported effect size: Hearing loss without hearing aids aHR 1.20 (95% CI 1.13-1.27); with hearing aids aHR 1.06 (1.01-1.10).

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Cantuaria, M. L., Pedersen, E. R., Waldorff, F. B., Wermuth, L., Pedersen, K. M., Poulsen, A. H., et al. (2024). Hearing Loss, Hearing Aid Use, and Risk of Dementia in Older Adults. JAMA Otolaryngology-Head & Neck Surgery. https://doi.org/10.1001/jamaoto.2023.3509

Vancouver

Cantuaria ML, Pedersen ER, Waldorff FB, Wermuth L, Pedersen KM, Poulsen AH, et al. Hearing Loss, Hearing Aid Use, and Risk of Dementia in Older Adults. JAMA Otolaryngology-Head & Neck Surgery. 2024. doi:10.1001/jamaoto.2023.3509. PMID: 38175662.

BibTeX

@article{cantuaria2024-38175662,
  author  = {Cantuaria, M. L. and Pedersen, E. R. and Waldorff, F. B. and Wermuth, L. and Pedersen, K. M. and Poulsen, A. H. and others},
  title   = {{Hearing Loss, Hearing Aid Use, and Risk of Dementia in Older Adults}},
  journal = {JAMA Otolaryngology-Head \& Neck Surgery},
  year    = {2024},
  doi     = {10.1001/jamaoto.2023.3509},
  pmid    = {38175662},
  url     = {https://doi.org/10.1001/jamaoto.2023.3509}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.

Key findings

Why it matters

This population-based cohort study of 573,088 people in Southern Denmark found that hearing loss was associated with an increased risk of dementia, with severe hearing loss linked to higher risk. It supports hearing loss as a risk factor for dementia, but it does not show that hearing aids prevent or treat dementia.

Study details

Limitations

Hearing-aid users may be healthier or more engaged; hearing loss only captured when people attended a public clinic; Danish registry diagnoses.

How this study scored 70/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record left out, no data; Study design 7 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 4 of 4; Effect reported 3 of 3; Studied in people 3 of 3; Randomized / blinded 0 of 2; Times cited 5 of 7; Citations per year 4 of 5; Impact for its field and year 5 of 6; Cited by studies here 2 of 6; Still being cited 3 of 4; Senior author's track record 1 of 4; Institution's track record 1 of 3; Multicenter collaboration 2 of 3; Indexed in PubMed 2 of 2; Free to read left out, no data. 66 of the 94 points it could be judged on, which is 70 of 100. Total 70 of 100.66 of the 94 points we could judge = 70 of 100

Published in a peer-reviewed journal, and it is a cohort study following people over time. Scored zero for randomized / blinded because the record does not state it. We have no data on journal's citation record and free to read, so those were left out: it earned 66 of the 94 points we could judge it on, which is 70 out of 100.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (JAMA Otolaryngology-Head & Neck Surgery)
Journal's citation record — / 4 No journal record from OpenAlex — left out of this score
Study design 7 / 12 A cohort study following people over time
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2024 — within 3 year(s) of the newest study here
Sample size 4 / 4 573,088 participants
Effect reported 3 / 3 Effect reported with a statistic (interval, p-value, ratio or similar)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 5 / 7 Cited 109 times (OpenAlex, 2026-10-10)
Citations per year 4 / 5 27.2 citations a year over 4 year(s) since 2024
Impact for its field and year 5 / 6 Cited 25.7× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 2 / 6 Cited by 8 other studies in this library
Still being cited 3 / 4 Cited 109 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 1 / 4 Last-listed author Jesper Hvass Schmidt: h-index 18 (OpenAlex, whole career)
Institution's track record 1 / 3 University of Copenhagen: institution h-index 1,378 (OpenAlex)
Multicenter collaboration 2 / 3 OpenAlex lists 6 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 38175662)
Free to read — / 2 Access not recorded — left out of this score
Points 66 / 94 Scored on 18 of 20 parts. We have no data for the rest, so they are left out: 66 of the 94 points we could judge it on is 70 out of 100.
Total 70 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — PubMed Central lists this copy as free to read: the link above (checked 10 Oct 2026).

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Later studies that cite this one

8 studies in the alzhub library list this one in their references.

Related studies in Prevention and risk from nearby years

Also tagged “biobank”

1,084 studies in the library carry the topic tag “biobank”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,084 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Prevention and risk

See all studies in Prevention and risk →